Difficulty: Medium
Average Score: 81%
Practice
A 50-year-old postmenopausal patient who has had a hysterectomy has moderate to severe vasomotor symptoms and is discussing estrogen therapy (ET) with the nurse. The patient is concerned about adverse effects of ET. The nurse will tell her that:
Correct answer
D
Rationale
In this scenario, the correct answer is D) transdermal preparations have fewer side effects. Transdermal estrogen therapy bypasses the liver, reducing the risk of adverse effects such as thromboembolic events compared to oral estrogen therapy. This route of administration also provides more stable hormone levels, leading to fewer fluctuations and potentially fewer side effects.
Option A is incorrect because adding progesterone can actually increase the risk of side effects, not reduce them. Option B is not the best choice for addressing vasomotor symptoms in this patient. Option C is incorrect as age is not the sole determinant of the likelihood of experiencing side effects from estrogen therapy.
In an educational context, it is crucial for nurses to understand the different administration routes and their implications when discussing hormone therapy with patients. By choosing the most appropriate route based on individual patient factors, nurses can help optimize treatment outcomes and minimize adverse effects. This rationale highlights the importance of personalized care and evidence-based practice in pharmacological management across the lifespan.
Option A is incorrect because adding progesterone can actually increase the risk of side effects, not reduce them. Option B is not the best choice for addressing vasomotor symptoms in this patient. Option C is incorrect as age is not the sole determinant of the likelihood of experiencing side effects from estrogen therapy.
In an educational context, it is crucial for nurses to understand the different administration routes and their implications when discussing hormone therapy with patients. By choosing the most appropriate route based on individual patient factors, nurses can help optimize treatment outcomes and minimize adverse effects. This rationale highlights the importance of personalized care and evidence-based practice in pharmacological management across the lifespan.